001-11507 | 13-5593032 | |||||||||||||
(Commission File Number) | (IRS Employer Identification No.) | |||||||||||||
111 River Street, Hoboken New Jersey |
07030 |
|||||||||||||
(Address of principal executive offices) | (Zip Code) | |||||||||||||
Registrant’s telephone number, including area code: | (201) 748-6000 |
|||||||||||||
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Class A Common Stock, par value $1.00 per share | WLY | New York Stock Exchange | ||||||||||||
Class B Common Stock, par value $1.00 per share | WLYB | New York Stock Exchange |
JOHN WILEY & SONS, INC. | ||||||||||||||
(Registrant) | ||||||||||||||
By | /s/ Brian A. Napack | |||||||||||||
Brian A. Napack | ||||||||||||||
President and Chief Executive Officer |
||||||||||||||
By | /s/ Christina Van Tassell | |||||||||||||
Christina Van Tassell | ||||||||||||||
Executive Vice President and Chief Financial Officer |
||||||||||||||
Dated: June 15, 2023 |
Metric ($millions, except EPS) |
Fiscal 2023
All Company
|
Fiscal 2023
Ex-Divestitures
|
Fiscal 2024 Outlook
Ex-Divestitures
|
||||||||
Adjusted Revenue* | $2,020 | $1,627 | $1,580 to $1,630 | ||||||||
Research | $1,080 | Flat (+3% ex-Hindawi) | |||||||||
Learning | $547 | Down by low single digits | |||||||||
Adjusted EBITDA* | $422 | $379 | $305 to $330 | ||||||||
Adjusted EPS* | $3.84 | $3.48 | $2.05 to $2.40 |
Three Months Ended April 30, |
Year Ended April 30, |
||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Revenue, net | $ | 526,127 | $ | 545,653 | $ | 2,019,900 | $ | 2,082,928 | |||||||||||||||
Costs and expenses: | |||||||||||||||||||||||
Cost of sales | 174,157 | 187,004 | 692,541 | 700,658 | |||||||||||||||||||
Operating and administrative expenses | 245,821 | 279,331 | 1,037,399 | 1,079,585 | |||||||||||||||||||
Impairment of goodwill (3) |
— | — | 99,800 | — | |||||||||||||||||||
Restructuring and related charges (credits) | 4,185 | (266) | 49,389 | (1,427) | |||||||||||||||||||
Amortization of intangible assets | 19,492 | 21,153 | 84,881 | 84,836 | |||||||||||||||||||
Total costs and expenses | 443,655 | 487,222 | 1,964,010 | 1,863,652 | |||||||||||||||||||
Operating income | 82,472 | 58,431 | 55,890 | 219,276 | |||||||||||||||||||
As a % of revenue | 15.7 | % | 10.7 | % | 2.8 | % | 10.5 | % | |||||||||||||||
Interest expense | (10,560) | (5,063) | (37,745) | (19,802) | |||||||||||||||||||
Foreign exchange transaction gains (losses) | 611 | (1,704) | 894 | (3,192) | |||||||||||||||||||
Gain on sale of businesses and certain assets | 10,177 | — | 10,177 | 3,694 | |||||||||||||||||||
Other income, net | 2,908 | 161 | 3,884 | 9,685 | |||||||||||||||||||
Income before taxes | 85,608 | 51,825 | 33,100 | 209,661 | |||||||||||||||||||
Provision for income taxes | 17,264 | 8,679 | 15,867 | 61,352 | |||||||||||||||||||
Effective tax rate | 20.2 | % | 16.7 | % | 47.9 | % | 29.3 | % | |||||||||||||||
Net income | $ | 68,344 | $ | 43,146 | $ | 17,233 | $ | 148,309 | |||||||||||||||
As a % of revenue | 13.0 | % | 7.9 | % | 0.9 | % | 7.1 | % | |||||||||||||||
Earnings per share | |||||||||||||||||||||||
Basic | $ | 1.23 | $ | 0.78 | $ | 0.31 | $ | 2.66 | |||||||||||||||
Diluted | $ | 1.22 | $ | 0.76 | $ | 0.31 | $ | 2.62 | |||||||||||||||
Weighted average number of common shares outstanding | |||||||||||||||||||||||
Basic | 55,355 | 55,668 | 55,558 | 55,759 | |||||||||||||||||||
Diluted | 56,137 | 56,529 | 56,355 | 56,598 |
Notes: | ||
(1) The supplementary information included in this press release for the three months and year ended April 30, 2023 is preliminary and subject to change prior to the filing of our upcoming Annual Report on Form 10-K with the Securities and Exchange Commission. | ||
(2) All amounts are approximate due to rounding. | ||
(3) As previously announced, in the third quarter of fiscal year 2023 we reorganized our Education lines of business into two new customer-centric segments. Our new segment reporting structure consists of three reportable segments which includes Research (no changes), Academic, and Talent, as well as a Corporate expense category (no change). As a result of this realignment, we were required to test goodwill for impairment immediately before and after the realignment. Prior to the realignment, we concluded that the fair value of the Education Services reporting unit was below its carrying value, which resulted in a pre-tax non-cash goodwill impairment of $31.0 million. After the realignment, we concluded that the fair value of the University Services reporting unit within the Academic segment was below its carrying value which resulted in an additional pre-tax non-cash goodwill impairment of $68.8 million. | ||
Reconciliation of US GAAP EPS to Non-GAAP Adjusted EPS | |||||||||||||||||||||||
Three Months Ended April 30, |
Year Ended
April 30,
|
||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
US GAAP Earnings Per Share - Diluted | $ | 1.22 | $ | 0.76 | $ | 0.31 | $ | 2.62 | |||||||||||||||
Adjustments: | |||||||||||||||||||||||
Impairment of goodwill | 0.09 | — | 1.77 | — | |||||||||||||||||||
Legal settlement (3) |
— | — | 0.05 | — | |||||||||||||||||||
Pension income related to the wind up of the Russia plan (4) |
(0.02) | — | (0.02) | — | |||||||||||||||||||
Restructuring and related charges (credits) | 0.06 | — | 0.66 | (0.02) | |||||||||||||||||||
Foreign exchange (gains) losses on intercompany transactions, including the write off of certain cumulative translation adjustments (4) |
(0.01) | 0.02 | 0.01 | 0.02 | |||||||||||||||||||
Amortization of acquired intangible assets (5) |
0.26 | 0.29 | 1.21 | 1.21 | |||||||||||||||||||
Gain on sale of businesses and certain assets (6) |
(0.11) | — | (0.11) | (0.05) | |||||||||||||||||||
Income tax adjustments (8) |
(0.04) | 0.01 | (0.04) | 0.38 | |||||||||||||||||||
Non-GAAP Adjusted Earnings Per Share - Diluted | $ | 1.45 | $ | 1.08 | $ | 3.84 | $ | 4.16 | |||||||||||||||
Reconciliation of US GAAP Income Before Taxes to Non-GAAP Adjusted Income Before Taxes | |||||||||||||||||||||||
(amounts in thousands) |
Three Months Ended April 30, |
Year Ended
April 30,
|
|||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
US GAAP Income Before Taxes | $ | 85,608 | $ | 51,825 | $ | 33,100 | $ | 209,661 | |||||||||||||||
Pretax Impact of Adjustments: | |||||||||||||||||||||||
Impairment of goodwill | — | — | 99,800 | — | |||||||||||||||||||
Legal settlement (3) |
— | — | 3,671 | — | |||||||||||||||||||
Pension income related to the wind up of the Russia plan (4) |
(1,750) | — | (1,750) | — | |||||||||||||||||||
Restructuring and related charges (credits) | 4,185 | (266) | 49,389 | (1,427) | |||||||||||||||||||
Foreign exchange (gains) losses on intercompany transactions, including the write off of certain cumulative translation adjustments (4) |
(449) | 1,019 | 457 | 1,513 | |||||||||||||||||||
Amortization of acquired intangible assets (5) |
20,566 | 22,265 | 89,177 | 89,346 | |||||||||||||||||||
Gain on sale of businesses and certain assets (6) |
(10,177) | — | (10,177) | (3,694) | |||||||||||||||||||
Non-GAAP Adjusted Income Before Taxes | $ | 97,983 | $ | 74,843 | $ | 263,667 | $ | 295,399 | |||||||||||||||
Reconciliation of US GAAP Income Tax Provision to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate | |||||||||||||||||||||||
US GAAP Income Tax Provision | $ | 17,264 | $ | 8,679 | $ | 15,867 | $ | 61,352 | |||||||||||||||
Income Tax Impact of Adjustments (7) |
|||||||||||||||||||||||
Impairment of goodwill | (4,857) | — | — | — | |||||||||||||||||||
Legal settlement (3) |
— | — | 716 | — | |||||||||||||||||||
Pension income related to the wind up of the Russia plan (4) |
(437) | — | (437) | — | |||||||||||||||||||
Restructuring and related charges (credits) | 992 | (142) | 12,151 | (260) | |||||||||||||||||||
Foreign exchange (gains) losses on intercompany transactions, including the write off of certain cumulative translation adjustments (4) |
(142) | 41 | 132 | 597 | |||||||||||||||||||
Amortization of acquired intangible assets (5) |
5,372 | 6,017 | 20,183 | 20,816 | |||||||||||||||||||
Gain on sale of businesses and certain assets (6) |
(3,860) | — | (3,860) | (922) | |||||||||||||||||||
Income Tax Adjustments: | |||||||||||||||||||||||
Impact of increase in UK statutory rate on deferred tax balances (8) |
2,370 | (689) | 2,370 | (21,415) | |||||||||||||||||||
Non-GAAP Adjusted Income Tax Provision | $ | 16,702 | $ | 13,906 | $ | 47,122 | $ | 60,168 | |||||||||||||||
US GAAP Effective Tax Rate | 20.2 | % | 16.7 | % | 47.9 | % | 29.3 | % | |||||||||||||||
Non-GAAP Adjusted Effective Tax Rate | 17.0 | % | 18.6 | % | 17.9 | % | 20.4 | % |
Notes: | |||||
(1) See Explanation of Usage of Non-GAAP Performance Measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors. The supplementary information included in this press release for the three months and year ended April 30, 2023 is preliminary and subject to change prior to the filing of our upcoming Annual Report on Form 10-K with the Securities and Exchange Commission. | |||||
(2) All amounts are approximate due to rounding. | |||||
(3) We settled a litigation matter related to consideration for a previous acquisition for $3.7 million during the three months ended January 31, 2023. This amount is reflected in Operating and administrative expenses on our Condensed Consolidated Statements of Income. | |||||
(4) In the three months and year ended April 30, 2023, due to the closure of our operations in Russia, there was a curtailment and settlement credit due to the wind up of the Russia Pension Plan of $1.8 million which is reflected in Other income, net on our Condensed Consolidated Statements of Income. In addition, we wrote off the $1.1 million cumulative translation adjustment in earnings because the Russia entity was deemed substantially liquidated. This amount is reflected in Foreign exchange gains (losses) on our Condensed Consolidated Statements of Income. | |||||
(5) Reflects the amortization of intangible assets established on the opening balance sheet for an acquired business. This includes the amortization of intangible assets such as developed technology, customer relationships, tradenames, etc., which is reflected in the "Amortization of intangible assets" line in the Condensed Consolidated Statements of Income. It also includes the amortization of acquired product development assets, which is reflected in Cost of sales in the Condensed Consolidated Statements of Income. | |||||
(6) In the three months and year ended April 30, 2023, the gain on sale of businesses is due to the sale of Wiley's Efficient Learning test prep portfolio business and our advancement courses business, which were both included in our Academic segment, and resulted in a pretax gain of approximately $10.2 million (net of tax gain of $6.3 million). For the year ended April 30, 2022, the gain on sale of certain assets is due to the sale of our world languages product portfolio, which was included in our Academic segment, and resulted in a pretax gain of approximately $3.7 million (net of tax gain of $2.8 million). | |||||
(7) For the three months ended April 30, 2023, the tax impact was $4.3 million of current tax benefit and $3.7 million of deferred taxes. For the year ended April 30, 2023, substantially all of the tax impact was from deferred taxes. For the three months and year ended April 30, 2022, substantially all of the tax impact was from deferred taxes. | |||||
(8) In the three months ended July 31, 2021, the UK enacted legislation that increased its statutory rate from 19% to 25% effective April 1, 2023. This resulted in a $21.4 million non-cash deferred tax expense from the re-measurement of the Company’s applicable UK net deferred tax liabilities during the three months ended July 31, 2021. These adjustments impacted deferred taxes. For the three months and year ended April 30, 2023, we recorded a $2.4 million non-cash deferred tax benefit related to pensions due to the UK statutory rate change. These adjustments impacted deferred taxes. |
Three Months Ended April 30, |
Year Ended April 30, |
||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Net Income | $ | 68,344 | $ | 43,146 | $ | 17,233 | $ | 148,309 | |||||||||||||||
Interest expense | 10,560 | 5,063 | 37,745 | 19,802 | |||||||||||||||||||
Provision for income taxes | 17,264 | 8,679 | 15,867 | 61,352 | |||||||||||||||||||
Depreciation and amortization | 50,111 | 52,686 | 213,253 | 215,170 | |||||||||||||||||||
Non-GAAP EBITDA | 146,279 | 109,574 | 284,098 | 444,633 | |||||||||||||||||||
Impairment of goodwill | — | — | 99,800 | — | |||||||||||||||||||
Legal settlement | — | — | 3,671 | — | |||||||||||||||||||
Restructuring and related charges (credits) | 4,185 | (266) | 49,389 | (1,427) | |||||||||||||||||||
Foreign exchange (gains) losses on intercompany transactions, including the write off of certain cumulative translation adjustments | (611) | 1,704 | (894) | 3,192 | |||||||||||||||||||
Gain on sale of businesses and certain assets | (10,177) | — | (10,177) | (3,694) | |||||||||||||||||||
Other income, net | (2,908) | (161) | (3,884) | (9,685) | |||||||||||||||||||
Non-GAAP Adjusted EBITDA | $ | 136,768 | $ | 110,851 | $ | 422,003 | $ | 433,019 | |||||||||||||||
Adjusted EBITDA Margin | 26.0 | % | 20.3 | % | 20.9 | % | 20.8 | % |
Notes: | ||
(1) See Explanation of Usage of Non-GAAP Performance Measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors. The supplementary information included in this press release for the three months and year ended April 30, 2023 is preliminary and subject to change prior to the filing of our upcoming Annual Report on Form 10-K with the Securities and Exchange Commission. |
% Change | |||||||||||||||||||||||
Three Months Ended April 30, |
Favorable (Unfavorable) | ||||||||||||||||||||||
2023 | 2022 (3) |
Reported | Constant Currency |
||||||||||||||||||||
Research: | |||||||||||||||||||||||
Revenue, net | |||||||||||||||||||||||
Research Publishing (4) |
$ | 240,889 | $ | 257,025 | -6 | % | -5 | % | |||||||||||||||
Research Solutions (4) |
39,550 | 41,067 | -4 | % | -2 | % | |||||||||||||||||
Total Revenue, net | $ | 280,439 | $ | 298,092 | -6 | % | -5 | % | |||||||||||||||
Contribution to Profit | $ | 82,640 | $ | 76,985 | 7 | % | 6 | % | |||||||||||||||
Adjustments: | |||||||||||||||||||||||
Restructuring charges | 605 | — | # | # | |||||||||||||||||||
Non-GAAP Adjusted Contribution to Profit | $ | 83,245 | $ | 76,985 | 8 | % | 7 | % | |||||||||||||||
Depreciation and amortization | 22,700 | 23,759 | 4 | % | 3 | % | |||||||||||||||||
Non-GAAP Adjusted EBITDA | $ | 105,945 | $ | 100,744 | 5 | % | 4 | % | |||||||||||||||
Adjusted EBITDA margin | 37.8 | % | 33.8 | % | |||||||||||||||||||
Academic: | |||||||||||||||||||||||
Revenue, net | |||||||||||||||||||||||
Academic Publishing | $ | 127,024 | $ | 130,965 | -3 | % | -1 | % | |||||||||||||||
University Services | 55,764 | 58,405 | -5 | % | -4 | % | |||||||||||||||||
Total Revenue, net | $ | 182,788 | $ | 189,370 | -3 | % | -2 | % | |||||||||||||||
Contribution to Profit | $ | 36,512 | $ | 22,542 | 62 | % | 63 | % | |||||||||||||||
Adjustments: | |||||||||||||||||||||||
Restructuring charges (credits) | 275 | (123) | # | # | |||||||||||||||||||
Impairment of goodwill | — | — | # | # | |||||||||||||||||||
Non-GAAP Adjusted Contribution to Profit | $ | 36,787 | $ | 22,419 | 64 | % | 65 | % | |||||||||||||||
Depreciation and amortization | 18,194 | 20,099 | 9 | % | 9 | % | |||||||||||||||||
Non-GAAP Adjusted EBITDA | $ | 54,981 | $ | 42,518 | 29 | % | 30 | % | |||||||||||||||
Adjusted EBITDA margin | 30.1 | % | 22.5 | % | |||||||||||||||||||
Talent: | |||||||||||||||||||||||
Total Revenue, net | $ | 62,900 | $ | 58,191 | 8 | % | 12 | % | |||||||||||||||
Contribution to Profit | $ | 7,516 | $ | 7,566 | -1 | % | 2 | % | |||||||||||||||
Adjustments: | |||||||||||||||||||||||
Restructuring charges (credits) | 609 | (222) | # | # | |||||||||||||||||||
Non-GAAP Adjusted Contribution to Profit | $ | 8,125 | $ | 7,344 | 11 | % | 14 | % | |||||||||||||||
Depreciation and amortization | 4,760 | 4,693 | -1 | % | -3 | % | |||||||||||||||||
Non-GAAP Adjusted EBITDA | $ | 12,885 | $ | 12,037 | 7 | % | 10 | % | |||||||||||||||
Adjusted EBITDA margin | 20.5 | % | 20.7 | % | |||||||||||||||||||
Corporate Expenses: | $ | (44,196) | $ | (48,662) | 9 | % | 7 | % | |||||||||||||||
Adjustments: | |||||||||||||||||||||||
Restructuring charges | 2,696 | 79 | # | # | |||||||||||||||||||
Non-GAAP Adjusted Contribution to Profit | $ | (41,500) | $ | (48,583) | 15 | % | 13 | % | |||||||||||||||
Depreciation and amortization | 4,457 | 4,135 | -8 | % | -9 | % | |||||||||||||||||
Non-GAAP Adjusted EBITDA | $ | (37,043) | $ | (44,448) | 17 | % | 15 | % | |||||||||||||||
Consolidated Results: | |||||||||||||||||||||||
Revenue, net | $ | 526,127 | $ | 545,653 | -4 | % | -2 | % | |||||||||||||||
Operating Income | $ | 82,472 | $ | 58,431 | 41 | % | 39 | % | |||||||||||||||
Adjustments: | |||||||||||||||||||||||
Restructuring charges (credits) | 4,185 | (266) | # | # | |||||||||||||||||||
Non-GAAP Adjusted Operating Income | $ | 86,657 | $ | 58,165 | 49 | % | 47 | % | |||||||||||||||
Depreciation and amortization | 50,111 | 52,686 | 5 | % | 4 | % | |||||||||||||||||
Non-GAAP Adjusted EBITDA | $ | 136,768 | $ | 110,851 | 23 | % | 23 | % | |||||||||||||||
Adjusted EBITDA margin | 26.0 | % | 20.3 | % |
Notes: | ||
(1) The supplementary information included in this press release for the three months and year ended April 30, 2023 is preliminary and subject to change prior to the filing of our upcoming Annual Report on Form 10-K with the Securities and Exchange Commission. | ||
(2) All amounts are approximate due to rounding. | ||
(3) In the three months ended January 31, 2023, we reorganized our Education lines of business into two new customer-centric segments. The Academic segment addresses the university customer group and includes Academic Publishing and University Services. The Talent segment addresses the corporate customer group and will be focused on delivering training, sourcing, and upskilling solutions. Our new segment reporting structure consists of three reportable segments which includes Research (no changes), Academic, and Talent, as well as a Corporate expense category (no change), which includes certain costs that are not allocated to the reportable segments. Prior period segment results have been revised to the new segment presentation. There were no changes to our consolidated financial results. | ||
(4) As previously announced in May 2022, our revenue by product type previously referred to as Research Platforms was changed to Research Solutions. Research Solutions includes infrastructure and publishing services that help societies and corporations thrive in a complex knowledge ecosystem. In addition to Platforms (Atypon), certain product offerings such as corporate sales which included the recent acquisitions of Madgex Holdings Limited (Madgex), and Bio-Rad Laboratories Inc.’s Informatics products (Informatics) that were previously included in Research Publishing moved to Research Solutions to align with our strategic focus. Research Solutions also includes product offerings related to certain recent acquisitions such as J&J, and EJP. Prior period results have been revised to the new presentation. There were no changes to the total Research segment or our consolidated financial results. The revenue was $24.9 million for the three months ended April 30, 2022, $93.3 million for the year ended April 30, 2022, and $80.3 million for the year ended April 30, 2021. | ||
(5) In the three months ended January 31, 2023, we settled a litigation matter related to consideration for a previous acquisition for $3.7 million. | ||
(6) On January 1, 2020, Wiley acquired mthree, a talent placement provider that addresses the IT skills gap by finding, training, and placing job-ready technology talent in roles with leading corporations worldwide. Its results of operations are included in our Talent segment. In late May 2022, Wiley renamed the mthree talent development solution to Wiley Edge and discontinued use of the mthree trademark during the three months ended July 31, 2022. As a result of these actions, we determined that a revision of the useful life was warranted, and the intangible asset was fully amortized over its remaining useful life resulting in accelerated amortization expense of $4.6 million in the three months ended July 31, 2022. | ||
# Variance greater than 100% |
% Change | |||||||||||||||||||||||
Year Ended April 30, |
Favorable (Unfavorable) | ||||||||||||||||||||||
2023 | 2022 (3) |
Reported | Constant Currency |
||||||||||||||||||||
Research: | |||||||||||||||||||||||
Revenue, net | |||||||||||||||||||||||
Research Publishing (4) |
$ | 926,773 | $ | 963,715 | -4 | % | -1 | % | |||||||||||||||
Research Solutions (4) |
153,538 | 147,628 | 4 | % | 7 | % | |||||||||||||||||
Total Revenue, net | $ | 1,080,311 | $ | 1,111,343 | -3 | % | 0 | % | |||||||||||||||
Contribution to Profit | $ | 281,802 | $ | 294,989 | -4 | % | -4 | % | |||||||||||||||
Adjustments: | |||||||||||||||||||||||
Restructuring charges | 2,182 | 238 | # | # | |||||||||||||||||||
Non-GAAP Adjusted Contribution to Profit | $ | 283,984 | $ | 295,227 | -4 | % | -3 | % | |||||||||||||||
Depreciation and amortization | 93,008 | 94,899 | 2 | % | -1 | % | |||||||||||||||||
Non-GAAP Adjusted EBITDA | $ | 376,992 | $ | 390,126 | -3 | % | -2 | % | |||||||||||||||
Adjusted EBITDA margin | 34.9 | % | 35.1 | % | |||||||||||||||||||
Academic: | |||||||||||||||||||||||
Revenue, net | |||||||||||||||||||||||
Academic Publishing | $ | 481,752 | $ | 531,705 | -9 | % | -7 | % | |||||||||||||||
University Services | 208,656 | 227,407 | -8 | % | -8 | % | |||||||||||||||||
Total Revenue, net | $ | 690,408 | $ | 759,112 | -9 | % | -7 | % | |||||||||||||||
Contribution to Profit | $ | (41,887) | $ | 91,717 | # | # | |||||||||||||||||
Adjustments: | |||||||||||||||||||||||
Restructuring charges (credits) | 10,366 | (470) | # | # | |||||||||||||||||||
Impairment of goodwill | 99,800 | — | # | # | |||||||||||||||||||
Non-GAAP Adjusted Contribution to Profit | $ | 68,279 | $ | 91,247 | -25 | % | -23 | % | |||||||||||||||
Depreciation and amortization | 79,741 | 81,721 | 2 | % | 1 | % | |||||||||||||||||
Non-GAAP Adjusted EBITDA | $ | 148,020 | $ | 172,968 | -14 | % | -13 | % | |||||||||||||||
Adjusted EBITDA margin | 21.4 | % | 22.8 | % | |||||||||||||||||||
Talent: | |||||||||||||||||||||||
Total Revenue, net | $ | 249,181 | $ | 212,473 | 17 | % | 24 | % | |||||||||||||||
Contribution to Profit | $ | 25,404 | $ | 23,936 | 6 | % | 10 | % | |||||||||||||||
Adjustments: | |||||||||||||||||||||||
Restructuring charges | 3,009 | 23 | # | # | |||||||||||||||||||
Accelerated amortization of an intangible asset (6) |
4,594 | — | # | # | |||||||||||||||||||
Non-GAAP Adjusted Contribution to Profit | $ | 33,007 | $ | 23,959 | 38 | % | 41 | % | |||||||||||||||
Depreciation and amortization | 19,448 | 21,997 | 12 | % | 7 | % | |||||||||||||||||
Non-GAAP Adjusted EBITDA | $ | 52,455 | $ | 45,956 | 14 | % | 18 | % | |||||||||||||||
Adjusted EBITDA margin | 21.1 | % | 21.6 | % | |||||||||||||||||||
Corporate Expenses: | $ | (209,429) | $ | (191,366) | -9 | % | -13 | % | |||||||||||||||
Adjustments: | |||||||||||||||||||||||
Restructuring charges (credits) | 33,832 | (1,218) | # | # | |||||||||||||||||||
Legal settlement (5) |
3,671 | — | # | # | |||||||||||||||||||
Non-GAAP Adjusted Contribution to Profit | $ | (171,926) | $ | (192,584) | 11 | % | 7 | % | |||||||||||||||
Depreciation and amortization | 16,462 | 16,553 | 1 | % | -2 | % | |||||||||||||||||
Non-GAAP Adjusted EBITDA | $ | (155,464) | $ | (176,031) | 12 | % | 8 | % | |||||||||||||||
Consolidated Results: | |||||||||||||||||||||||
Revenue, net | $ | 2,019,900 | $ | 2,082,928 | -3 | % | 0 | % | |||||||||||||||
Operating Income | $ | 55,890 | $ | 219,276 | -75 | % | -76 | % | |||||||||||||||
Adjustments: | |||||||||||||||||||||||
Restructuring charges (credits) | 49,389 | (1,427) | # | # | |||||||||||||||||||
Impairment of goodwill | 99,800 | — | # | # | |||||||||||||||||||
Legal settlement (5) |
3,671 | — | # | # | |||||||||||||||||||
Accelerated amortization of an intangible asset (6) |
4,594 | — | # | # | |||||||||||||||||||
Non-GAAP Adjusted Operating Income | $ | 213,344 | $ | 217,849 | -2 | % | -3 | % | |||||||||||||||
Depreciation and amortization | 208,659 | 215,170 | 3 | % | 1 | % | |||||||||||||||||
Non-GAAP Adjusted EBITDA | $ | 422,003 | $ | 433,019 | -3 | % | -2 | % | |||||||||||||||
Adjusted EBITDA margin | 20.9 | % | 20.8 | % |
# Variance greater than 100% |
April 30, 2023 |
April 30, 2022 |
||||||||||
Assets: | |||||||||||
Current assets | |||||||||||
Cash and cash equivalents | $ | 106,714 | $ | 100,397 | |||||||
Accounts receivable, net | 310,121 | 331,960 | |||||||||
Inventories, net | 30,733 | 36,585 | |||||||||
Prepaid expenses and other current assets | 93,711 | 81,924 | |||||||||
Total current assets | 541,279 | 550,866 | |||||||||
Technology, property and equipment, net | 247,149 | 271,572 | |||||||||
Intangible assets, net | 854,794 | 931,429 | |||||||||
Goodwill | 1,204,050 | 1,302,142 | |||||||||
Operating lease right-of-use assets | 91,197 | 111,719 | |||||||||
Other non-current assets | 170,341 | 193,967 | |||||||||
Total assets | $ | 3,108,810 | $ | 3,361,695 | |||||||
Liabilities and shareholders' equity: | |||||||||||
Current liabilities | |||||||||||
Accounts payable | $ | 84,325 | $ | 77,438 | |||||||
Accrued royalties | 113,423 | 101,596 | |||||||||
Short-term portion of long-term debt | 5,000 | 18,750 | |||||||||
Contract liabilities | 504,695 | 538,126 | |||||||||
Accrued employment costs | 80,458 | 117,121 | |||||||||
Short-term portion of operating lease liabilities | 19,673 | 20,576 | |||||||||
Other accrued liabilities | 87,979 | 95,812 | |||||||||
Total current liabilities | 895,553 | 969,419 | |||||||||
Long-term debt | 743,292 | 768,277 | |||||||||
Accrued pension liability | 86,304 | 78,622 | |||||||||
Deferred income tax liabilities | 144,042 | 180,065 | |||||||||
Operating lease liabilities | 115,540 | 132,541 | |||||||||
Other long-term liabilities | 79,052 | 90,502 | |||||||||
Total liabilities | 2,063,783 | 2,219,426 | |||||||||
Shareholders' equity | 1,045,027 | 1,142,269 | |||||||||
Total liabilities and shareholders' equity | $ | 3,108,810 | $ | 3,361,695 |
Notes: | ||
(1) The supplementary information included in this press release for April 30, 2023 is preliminary and subject to change prior to the filing of our upcoming Annual Report on Form 10-K with the Securities and Exchange Commission. |
Year Ended April 30, |
|||||||||||
2023 | 2022 | ||||||||||
Operating activities: | |||||||||||
Net income | $ | 17,233 | $ | 148,309 | |||||||
Impairment of goodwill | 99,800 | — | |||||||||
Amortization of intangible assets | 84,881 | 84,836 | |||||||||
Amortization of product development assets | 32,366 | 35,162 | |||||||||
Depreciation and amortization of technology, property, and equipment | 96,006 | 95,172 | |||||||||
Other noncash charges | 85,419 | 80,050 | |||||||||
Net change in operating assets and liabilities | (138,634) | (104,429) | |||||||||
Net cash provided by operating activities | 277,071 | 339,100 | |||||||||
Investing activities: | |||||||||||
Additions to technology, property, and equipment | (81,155) | (88,843) | |||||||||
Product development spending | (22,958) | (27,015) | |||||||||
Businesses acquired in purchase transactions, net of cash acquired | (7,292) | (75,703) | |||||||||
Proceeds related to the sale of businesses and certain assets | 15,585 | 3,375 | |||||||||
Acquisitions of publication rights and other | (2,578) | (5,838) | |||||||||
Net cash used in investing activities | (98,398) | (194,024) | |||||||||
Financing activities: | |||||||||||
Net debt repayments | (38,934) | (10,996) | |||||||||
Cash dividends | (77,298) | (77,205) | |||||||||
Purchases of treasury shares | (35,000) | (30,000) | |||||||||
Other | (17,336) | (13,437) | |||||||||
Net cash used in financing activities | (168,568) | (131,638) | |||||||||
Effects of exchange rate changes on cash, cash equivalents and restricted cash | (3,570) | (7,070) | |||||||||
Change in cash, cash equivalents and restricted cash for period | 6,535 | 6,368 | |||||||||
Cash, cash equivalents and restricted cash - beginning | 100,727 | 94,359 | |||||||||
Cash, cash equivalents and restricted cash - ending | $ | 107,262 | $ | 100,727 | |||||||
CALCULATION OF NON-GAAP FREE CASH FLOW LESS PRODUCT DEVELOPMENT SPENDING (2) | |||||||||||
Year Ended April 30, |
|||||||||||
2023 | 2022 | ||||||||||
Net cash provided by operating activities | $ | 277,071 | $ | 339,100 | |||||||
Less: Additions to technology, property, and equipment | (81,155) | (88,843) | |||||||||
Less: Product development spending | (22,958) | (27,015) | |||||||||
Free cash flow less product development spending | $ | 172,958 | $ | 223,242 |
Notes: | ||
(1) The supplementary information included in this press release for the year ended April 30, 2023 is preliminary and subject to change prior to the filing of our upcoming Annual Report on Form 10-K with the Securities and Exchange Commission. | ||
(2) See Explanation of Usage of Non-GAAP Performance Measures included in this supplemental information. |